Clinical Trial: Efficacy and Safety of Levocetirizine and Fexofenadine in Reducing Symptoms of Seasonal Allergic Rhinitis
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: Trial to Compare the Efficacy and Safety of Levocetirizine 5 mg od and Fexofenadine 120 mg od in Reducing Symptoms of Seasonal Allergic Rhinitis in Grass Pollen Sensitized
Brief Summary: No information was yet available over the effect of levocetirizine in children under 12 years. The aim of this double-blind, placebo-controlled study was to assess the efficacy and safety of levocetirizine in children from 6 to 12 years old with perennial allergic rhinitis due to house dust mites.
Detailed Summary:
Sponsor: UCB Pharma
Current Primary Outcome: Change from baseline of the mean Major symptom complex score over the last 2 hours of a 24-hour coverage
Original Primary Outcome: Same as current
Current Secondary Outcome:
- The change from baseline of the mean MSC score over time interval 3
- the change from baseline of the mean MSC score over time intervals 1 and 4.
Original Secondary Outcome: Same as current
Information By: UCB Pharma
Dates:
Date Received: October 10, 2007
Date Started: September 2002
Date Completion:
Last Updated: December 11, 2013
Last Verified: September 2009
